Clayton Dubilier & Rice’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $230M | Hold |
100,000,000
| – | – | 64.37% | 1 |
|
2025
Q1 | $433M | Hold |
100,000,000
| – | – | 99.35% | 1 |
|
2024
Q4 | $190M | Hold |
100,000,000
| – | – | 98.65% | 1 |
|
2024
Q3 | $393M | Hold |
100,000,000
| – | – | 97.86% | 1 |
|
2024
Q2 | $654M | Hold |
100,000,000
| – | – | 98.81% | 1 |
|
2024
Q1 | $610M | Hold |
100,000,000
| – | – | 98.6% | 1 |
|
2023
Q4 | $1.26B | Hold |
100,000,000
| – | – | 33.69% | 2 |
|
2023
Q3 | $1.78B | Hold |
100,000,000
| – | – | 32.71% | 2 |
|
2023
Q2 | $1.73B | Sell |
100,000,000
-94,611,308
| -49% | -$1.64B | 25.39% | 2 |
|
2023
Q1 | $4.62B | Hold |
194,611,308
| – | – | 50.06% | 1 |
|
2022
Q4 | $3.14B | Hold |
194,611,308
| – | – | 44.59% | 1 |
|
2022
Q3 | $4.56B | Sell |
194,611,308
-11,337,500
| -6% | -$266M | 46.8% | 1 |
|
2022
Q2 | $4.5B | Hold |
205,948,808
| – | – | 39.73% | 1 |
|
2022
Q1 | $5.22B | Hold |
205,948,808
| – | – | 42.34% | 1 |
|
2021
Q4 | $5.56B | Hold |
205,948,808
| – | – | 39.77% | 2 |
|
2021
Q3 | $5.4B | Sell |
205,948,808
-18,769,369
| -8% | -$492M | 42.56% | 1 |
|
2021
Q2 | $9.12B | Buy |
+224,718,177
| New | +$9.12B | 75.77% | 1 |
|